Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-CLN3 Antibody (N380/95)

Catalog #:   RHG47202 Specific References (37) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: IHC, WB
Overview

Catalog No.

RHG47202

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Target

BTS, Battenin, Batten disease protein, Protein CLN3, CLN3

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Applications

IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

N380/95

Data Image
References

Fluorescence Correlation Spectroscopy as a Versatile Method to Define Aptamer-Protein Interactions with Single-Molecule Sensitivity., PMID:38124657

Clinical and molecular characterization of non-syndromic retinal dystrophy due to c.175G>A mutation in ceroid lipofuscinosis neuronal 3 (CLN3)., PMID:30446867

Secretion and function of Cln5 during the early stages of Dictyostelium development., PMID:30048658

Lack of specificity of antibodies raised against CLN3, the lysosomal/endosomal transmembrane protein mutated in juvenile Batten disease., PMID:29089465

Pharmacological Effects on Ceroid Lipofuscin and Neuronal Structure in Cln3 ∆ex7/8 Mouse Brain Cultures., PMID:28812237

Aptamers Binding to c-Met Inhibiting Tumor Cell Migration., PMID:26658271

FRET-assisted determination of CLN3 membrane topology., PMID:25051496

Osmotic stress changes the expression and subcellular localization of the Batten disease protein CLN3., PMID:23840424

Immunosuppression alters disease severity in juvenile Batten disease mice., PMID:20937531

Identification of alpha-fetoprotein as an autoantigen in juvenile Batten disease., PMID:17931875

IgG entry and deposition are components of the neuroimmune response in Batten disease., PMID:17070688

Distinct patterns of serum immunoreactivity as evidence for multiple brain-directed autoantibodies in juvenile neuronal ceroid lipofuscinosis., PMID:16972881

Two novel CLN5 mutations in a Portuguese patient with vLINCL: insights into molecular mechanisms of CLN5 deficiency., PMID:16814585

Defective lysosomal arginine transport in juvenile Batten disease., PMID:16251196

Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease., PMID:15728308

Glutamic acid decarboxylase autoimmunity in Batten disease and other disorders., PMID:15596740

Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway., PMID:15471887

CLN3L, a novel protein related to the Batten disease protein, is overexpressed in Cln3-/- mice and in Batten disease., PMID:15240430

Recruitment of Cdc28 by Whi3 restricts nuclear accumulation of the G1 cyclin-Cdk complex to late G1., PMID:14685274

Intracellular trafficking of CLN3, the protein underlying the childhood neurodegenerative disease, Batten disease., PMID:14644441

Characterization of Cln3p, the gene product responsible for juvenile neuronal ceroid lipofuscinosis, as a lysosomal integral membrane glycoprotein., PMID:14622109

Membrane topology of CLN3, the protein underlying Batten disease., PMID:12706816

An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease., PMID:12023984

Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies., PMID:11683962

CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease., PMID:11590129

CLN-3 protein is expressed in the pancreatic somatostatin-secreting delta cells., PMID:11589017

Tripeptidyl-peptidase I in neuronal ceroid lipofuscinoses and other lysosomal storage disorders., PMID:11589013

Histopathologic and immunocytochemical analysis of the retina and ocular tissues in Batten disease., PMID:10964839

Distinct subcellular localization patterns contribute to functional specificity of the Cln2 and Cln3 cyclins of Saccharomyces cerevisiae., PMID:10611233

Splicing variants in sheep CLN3, the gene underlying juvenile neuronal ceroid lipofuscinosis., PMID:10356317

Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL)., PMID:10332042

Tissue expression and subcellular localization of CLN3, the Batten disease protein., PMID:10191116

Posttranslational modification of CLN3 protein and its possible functional implication., PMID:10191114

Intracellular trafficking of the JNCL protein CLN3., PMID:10191111

Evidence for phosphorylation of CLN3 protein associated with Batten disease., PMID:9878558

Immunochemical localization of the Batten disease (CLN3) protein in retina., PMID:9344361

A V lambda x-bearing monoclonal antibody with similar specificity and sequence to encephalitogenic T cell receptors., PMID:7517973

Datasheet

Document Download

Anti-CLN3 Antibody (N380/95).pdf

 

$ 328
Product specifications
100 μg 328 1 mg 1640

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-CLN3 Antibody (N380/95) [RHG47202]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only